These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31400858)

  • 41. Increased stromal-cell-derived factor 1 enhances the homing of bone marrow derived mesenchymal stem cells in dilated cardiomyopathy in rats.
    Zhou YL; Zhang HF; Li XL; DI RM; Yao WM; Li DF; Feng JL; Huang J; Cao KJ; Fu M
    Chin Med J (Engl); 2010 Nov; 123(22):3282-7. PubMed ID: 21163131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Timing of erythropoietin modified mesenchymal stromal cell transplantation for the treatment of experimental bronchopulmonary dysplasia.
    Zhang Z; Sun C; Wang J; Jiang W; Xin Q; Luan Y
    J Cell Mol Med; 2018 Nov; 22(11):5759-5763. PubMed ID: 30160360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy.
    Sun CK; Chang LT; Sheu JJ; Chiang CH; Lee FY; Wu CJ; Chua S; Fu M; Yip HK
    Crit Care Med; 2009 Apr; 37(4):1197-205. PubMed ID: 19242323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury.
    Iop L; Chiavegato A; Callegari A; Bollini S; Piccoli M; Pozzobon M; Rossi CA; Calamelli S; Chiavegato D; Gerosa G; De Coppi P; Sartore S
    Cell Transplant; 2008; 17(6):679-94. PubMed ID: 18819256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy.
    Chen Y; Liu W; Li W; Gao C
    Exp Mol Pathol; 2010 Apr; 88(2):311-5. PubMed ID: 20005220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effects of CXCR3/HO‑1 gene‑modified BMMSCs on damaged intestinal epithelial cells: Role of the p38‑MAPK signaling pathway.
    Yin M; Shen Z; Yang L; Zheng W; Song H
    Int J Mol Med; 2019 May; 43(5):2086-2102. PubMed ID: 30864680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy.
    Zeinaloo A; Zanjani KS; Bagheri MM; Mohyeddin-Bonab M; Monajemzadeh M; Arjmandnia MH
    Pediatr Transplant; 2011 Dec; 15(8):E183-6. PubMed ID: 20880092
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
    Lim SY; Kim YS; Ahn Y; Jeong MH; Hong MH; Joo SY; Nam KI; Cho JG; Kang PM; Park JC
    Cardiovasc Res; 2006 Jun; 70(3):530-42. PubMed ID: 16563361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Erythropoietin enhances the therapy potency of autologous bone marrow stromal cells in a rat heart infarction model via phosphatidylinositol-3-kinase/Akt pathway].
    Zhang DG; Zhang FM; Zhang YQ; Zhou F; Gao X; Li CF; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):912-6. PubMed ID: 17217721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of dilated cardiomyopathy in rabbits with mesenchymal stem cell transplantation and platelet-rich plasma.
    Mörschbächer PD; Alves Garcez TN; Paz AH; Magrisso AB; Mello HF; Rolim VM; Neuwald EB; Driemeier D; Contesini EA; Cirne-Lima E
    Vet J; 2016 Mar; 209():180-5. PubMed ID: 26832807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
    Xia W; Zhang F; Xie C; Jiang M; Hou M
    Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment.
    Liu N; Tian J; Cheng J; Zhang J
    Exp Cell Res; 2013 Aug; 319(13):2019-2027. PubMed ID: 23624354
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Shenqi Yangxin decoction on high mobility group box 1 and inflammatory signal pathway in a rat model of dilated cardiomyopathy.
    Shen L; Xing Q; Lu S; Zhou Y; Zhou C; Li L
    J Tradit Chin Med; 2018 Dec; 38(6):862-871. PubMed ID: 32186133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and echocardiographic features in patients with dilated cardiomyopathy: wave intensity and diastolic abnormality analysis.
    Siniawski H; Unbehaun A; Lehmkuhl H; Susanne K; Schoen F; Hetzer R
    Przegl Lek; 2002; 59(8):562-7. PubMed ID: 12638320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy.
    Mushtaq M; DiFede DL; Golpanian S; Khan A; Gomes SA; Mendizabal A; Heldman AW; Hare JM
    J Cardiovasc Transl Res; 2014 Dec; 7(9):769-80. PubMed ID: 25354998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism.
    Poynter JA; Herrmann JL; Manukyan MC; Wang Y; Abarbanell AM; Weil BR; Brewster BD; Meldrum DR
    J Am Coll Surg; 2011 Aug; 213(2):253-60. PubMed ID: 21546276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.